FEP+ calculations predict a stereochemical SAR switch for first-in-class indoline NIK inhibitors for multiple myeloma
Jacoby, E., Vlijmen, H.V., Querolle, O., Stansfield, I., Meerpoel, L., Versele, M., Hynd, G., Attar, R.(2020) Future Drug Discov 2